title: FDG PET/CT for Management and Assessing Outcomes of Squamous Cell Cancer of the Oral Cavity.
abstract: OBJECTIVE
  FDG PET/CT has excellent diagnostic accuracy for detecting locoregional nodal and distant metastases, can be used to assess therapeutic response, and provides valuable information about prognosis in patients with oral cavity cancer. The aim of this article is to summarize the value of FDG PET/CT in the treatment of patients with squamous cell cancer of the oral cavity.
  
  
  CONCLUSIONS
  FDG PET/CT is a valuable imaging study in the management of oral squamous cell cancer and in predicting patient outcome.
authors.affiliation: 1 Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N Caroline St, JHOC 3235, Baltimore, MD 21287.
authors.forename: Mohammed A
authors.initials: MA
authors.lastname: Pasha
authors.affiliation: 1 Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N Caroline St, JHOC 3235, Baltimore, MD 21287.
authors.forename: Charles
authors.initials: C
authors.lastname: Marcus
authors.affiliation: 2 Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, MD.
authors.forename: Carole
authors.initials: C
authors.lastname: Fakhry
authors.affiliation: 3 Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD.
authors.forename: Hyunseok
authors.initials: H
authors.lastname: Kang
authors.affiliation: 4 Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins School of Medicine, Baltimore, MD.
authors.forename: Ana P
authors.initials: AP
authors.lastname: Kiess
authors.affiliation: 1 Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, 601 N Caroline St, JHOC 3235, Baltimore, MD 21287.|2 Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, MD.|3 Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD.|5 Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
authors.forename: Rathan M
authors.initials: RM
authors.lastname: Subramaniam
mesh_terms: D019788:Fluorodeoxyglucose F18; D006801:Humans; D008207:Lymphatic Metastasis / Q000000981:diagnostic imaging; D009062:Mouth Neoplasms / Q000000981:diagnostic imaging* / Q000628:therapy; D064847:Multimodal Imaging; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging / Q000628:therapy; D009367:Neoplasm Staging; D018307:Neoplasms, Squamous Cell / Q000000981:diagnostic imaging* / Q000628:therapy; D010347:Patient Care Planning; D049268:Positron-Emission Tomography; D011379:Prognosis; D019275:Radiopharmaceuticals; D016019:Survival Analysis; D014057:Tomography, X-Ray Computed
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18
keywords: PET/CT; oral cavity cancer; patient outcome; staging; therapy response